Matakina Technology raises $5.5 mln for export push | Scoop News
Summary
Founded by a group of four including a physicist and cancer and medical imaging specialists, Matakina has already achieved 157 installations in 32 countries. “Investors understand that the time is right, the market is ready and that Volpara Solutions is at the forefront of a global revolution in breast screening," said chief executive and biggest shareholder Ralph Highnam. "They want to be part of it.” He said the company was now set to tap further into the global breast screen imaging market, which was worth around $1.5 billion annually. Milford Funds’ Brooke Bone said Matakina’s product was gaining public interest and sales in the US and Europe. It recently completed installations in Turkey and Thailand and said it was hoping to soon finalise a contract with a multi-national conglomerate that would embed the product in the global market.